|
ARHGAP32 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.828250E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.236200E-03 |
| Normal-vs-Stage2 |
2.260600E-01 |
| Normal-vs-Stage3 |
6.764200E-02 |
| Normal-vs-Stage4 |
9.241900E-04 |
| Stage1-vs-Stage2 |
4.960000E-01 |
| Stage1-vs-Stage3 |
7.832800E-01 |
| Stage1-vs-Stage4 |
2.576400E-01 |
| Stage2-vs-Stage3 |
7.218400E-01 |
| Stage2-vs-Stage4 |
1.381430E-01 |
| Stage3-vs-Stage4 |
2.187400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.385770E-02 |
| Normal-vs-AfricanAmerican |
1.909900E-02 |
| Normal-vs-Asian |
4.158000E-02 |
| Caucasian-vs-AfricanAmerican |
6.289800E-01 |
| Caucasian-vs-Asian |
4.899600E-01 |
| AfricanAmerican-vs-Asian |
4.934400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.342820E-03 |
| Normal-vs-Female |
9.035400E-01 |
| Male-vs-Female |
1.607950E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.947700E-02 |
| Normal-vs-Extreme_Weight |
2.556300E-04 |
| Normal-vs-Obese |
1.400760E-01 |
| Normal-vs-Extreme_Obese |
4.544100E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.918500E-02 |
| Normal_Weight-vs-Obese |
6.614800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.912400E-01 |
| Extreme_Weight-vs-Obese |
1.005800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.374800E-01 |
| Obese-vs-Extreme_Obese |
4.652200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.004600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.881700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.138600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.192400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.062400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.573400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.764400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.213620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.468200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.091800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.183900E-03 |
| Normal-VS-Type2 PRCC |
7.742000E-03 |
| Normal-VS-KIRP CIMP |
3.644000E-01 |
| Normal-VS-Unclassified PRCC |
3.314400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.526600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.847600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.730400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.998600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.068000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.928200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.422400E-03 |
| Normal-vs-N1 |
1.560230E-01 |
| Normal-vs-N2 |
2.66449999952734E-07 |
| N0-vs-N1 |
4.109400E-01 |
| N0-vs-N2 |
1.496760E-03 |
| N1-vs-N2 |
2.596900E-03 |
|
|
